Journal profile

Annals of surgical oncology

Publisher: Springer
ISSN1068-9265 | 1534-4681 FormatPrint StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
3.35
Citation rate 1.75 6,334 total citations
h5-index 57 h5 depth signal
Cited share 42.2% 1,595 of 3,778
Total citations 6,334 Citation footprint
Metric signal 1.68 External metric anchor
Self-citation 10.4% 659 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United States 7,573
Japan 2,097
China 2,070
Italy 1,018
Netherlands 801

Citing Fields of Research

Oncology 5,347
Digestive Disorders 3,752
Breast Cancer 3,371
Liver & Colon Cancer 3,309
Abdominal Surgery 2,103

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 23,825 Articles tracked across the journal lifetime
Indexed publication set 3,778 1,595 cited publications
Last 12 months 2,172 181.0 publications/month
Open access share 27.7% 602 OA publications in the last year
Leading citing country United States 7,573 citing publications
Leading citing field Oncology 5,347 citing publications
Latest tracked publication 16 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v1n1, 1994-
PubMed
v1n1, 1994-
Index medicus
Active Coverage

Research Focus & Classification

Indexed Subjects

Breast Cancer Oncology Digestive Disorders Liver & Colon Cancer Abdominal Surgery

Issuing & Sponsoring Bodies

Contributor
Society of Surgical Oncology (U.S.)

Broad Categories

General Surgery Neoplasms Digestive Disorders Liver & Colon Cancer Breast Cancer Reproductive Health Lung Cancer

MeSH Descriptors

Neoplasms

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

04
Margo Nelis, Lily Zhang, Vijayakrishna K. Gadi et al.
Objective: Metaplastic breast carcinoma (MpBC) is a rare and aggressive subtype of breast cancer, often characterized by triple-negative (TN) receptor status and a limited response to standard chemotherapy. The optimal treatment strategy...

Bibliographical & Catalog Notes

Place of publication varies.

Also issued online.

Official journal of the Society of Surgical Oncology.